ZEMPLAR sol inj 2 mcg/ml 5 flac 1 ml
7680563120020
CH-56312
H05BX02
07.05.0.
Reimbursement limitations:
ZEMPLAR Amp
Pour le traitement de l'hyperparathyroïdie secondaire chez les patients atteints d'insuffisance rénale terminale (IRC de …
1 / 3
google
Details
- Product number
- 5631203
- CPT
- -
- Packaging group
- 5
- Unit
- Durchstechflasche(n)
- Composition
- paricalcitolum 2 µg, ethanolum 170 mg, propylenglycolum 310 mg, aqua ad iniectabile ad solutionem pro 1 ml.
Articles (1)
Zemplar 2 ug/1ml, Injektionslösung
Injektionslösung
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
170.0 MG | Substance | HNIDK |
|
(N/A)
|
310.0 MG | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 67.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2016
Authorization holder
AbbVie AG
6330 Cham
Authorization information
- Swissmedic authorization number
- 56312
- Drug name
- Zemplar, Injektionslösung
- Galenic form
- LSPA
- ATC Code
- H05BX02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 09/08/2004
- Authorization expiration date
- 31/12/9999
- IT number
- 07.05.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ZEMPLAR sol inj 2 mcg/ml 5 flac 1 ml
- Description (DE)
- ZEMPLAR Inj Lös 2 mcg/ml 5 Durchstf 1 ml
- Market launch
- 06/11/2007
- Narcotic (BTM)
- No